Understanding the New Weight Loss Medications Online
Medications such as semaglutide (Wegovy) and tirzepatide (Zepbound) have markedly impacted the treatment of obesity in the US. The mechanisms by which these medications assert their effects will be discussed. Benefits beyond weight loss will be elaborated. Finally, novel uses for these compounds will be mentioned.
Dr. Berrettini is a Professor of Psychiatry, at the University of Pennsylvania Perelman School of Medicine. He earned his MD degree (1977) Jefferson Medical College and PhD degree (Pharmacology, 1979) from Thomas Jefferson University. After Psychiatry residency training, he studied genetics of behavioral disorders at the National Institute of Mental Health for ten years. The author of more than 400 peer-reviewed publications, his research interests include genetics, pharmacogenetics and medical treatment of addictions, mood disorders, schizophrenia and anxiety disorders.
This event is free and open to the public and will take place online via Zoom. Registration is required.